Equity Profile

BAX

Baxter International Inc.

Health CareHealth Care Equipment$10.0B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Baxter International Inc. is a healthcare company that develops and provides a range of medical devices and therapies....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Not available

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is vital for long-term success.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

BAX Q2-2026 Earnings Preview

Context

Company Snapshot

Baxter International Inc. is a healthcare company that develops and provides a range of medical devices and therapies. With a focus on improving patient outcomes, Baxter plays a crucial role in the health care equipment sector, especially in areas like renal care and surgical products.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+5.06%

Avg Stock Reaction

-4.92%

Last Quarter Recap

In Q1-2026, Baxter reported an EPS of $0.36, exceeding expectations by 15.38%. The stock reacted positively, gaining 4.02% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of Baxter's earnings report, given the recent EPS beat. However, there is uncertainty due to mixed historical performance.

Bull Case

If Baxter can continue its trend of beating EPS expectations, it may signal strong operational efficiency and growth potential, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price, as seen in previous quarters.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability, and any significant deviation from expectations could lead to a sharp stock reaction.

How does Baxter plan to address cost management and gross margin improvements?

Investors will be keen to hear about strategies for improving margins, especially in a competitive healthcare market.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Baxter's ability to manage costs effectively, which could lead to better-than-expected margins and EPS.

Supporting Evidence

Baxter has a history of beating EPS estimates, which may not be fully reflected in current expectations.

Options pricing suggests a lower expected move than historical averages, indicating potential for a surprise.

The recent positive EPS surprise could indicate a trend of improving operational efficiency.

Key Risk

If gross margins improve significantly, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued earnings growth against historical performance and cost pressures.

Bull Confirmed If

An EPS of $0.40 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.30 would confirm the bear case, raising concerns about profitability and cost management.

Pre-Earnings Positioning

Options Market

Implied Move

±6.74%

Historical Avg

±9.7%

Pricing cheap

The options market is pricing in a move of about 6.74%, suggesting that traders expect some volatility around the earnings announcement.

Options are pricing ±6.7% while BAX has averaged ±9.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.5%

30d HV

40.0%

Calls (51K)P/C Ratio: 0.52Puts (20K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Baxter beats expectations, history suggests a potential stock increase of around 0.59%, confirming positive operational momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline of approximately 14.10%, reflecting investor disappointment and concerns about future performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on gross margins.
2Details on product demand trends, especially in key segments like renal care.
3Management's outlook on market conditions and competitive pressures.
4Guidance on future revenue growth and potential new product launches.
5Responses to any questions about regulatory changes affecting the healthcare sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

Insider activity

PreviewView

Jul

Company Snapshot

Baxter International Inc. is a healthcare company that develops and provides a range of medical devices and therapies....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Not available

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is vital for long-term success.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

BAX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+5.06%

Avg Stock Reaction

-4.92%

Last Quarter Recap

In Q1-2026, Baxter reported an EPS of $0.36, exceeding expectations by 15.38%. The stock reacted positively, gaining 4.02% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of Baxter's earnings report, given the recent EPS beat. However, there is uncertainty due to mixed historical performance.

Bull Case

If Baxter can continue its trend of beating EPS expectations, it may signal strong operational efficiency and growth potential, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price, as seen in previous quarters.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability, and any significant deviation from expectations could lead to a sharp stock reaction.

How does Baxter plan to address cost management and gross margin improvements?

Investors will be keen to hear about strategies for improving margins, especially in a competitive healthcare market.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Baxter's ability to manage costs effectively, which could lead to better-than-expected margins and EPS.

Supporting Evidence

Baxter has a history of beating EPS estimates, which may not be fully reflected in current expectations.

Options pricing suggests a lower expected move than historical averages, indicating potential for a surprise.

The recent positive EPS surprise could indicate a trend of improving operational efficiency.

Key Risk

If gross margins improve significantly, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued earnings growth against historical performance and cost pressures.

Bull Confirmed If

An EPS of $0.40 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.30 would confirm the bear case, raising concerns about profitability and cost management.

Pre-Earnings Positioning

Options Market

Implied Move

±6.74%

Historical Avg

±9.7%

Pricing cheap

The options market is pricing in a move of about 6.74%, suggesting that traders expect some volatility around the earnings announcement.

Options are pricing ±6.7% while BAX has averaged ±9.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.5%

30d HV

40.0%

Calls (51K)P/C Ratio: 0.52Puts (20K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Baxter beats expectations, history suggests a potential stock increase of around 0.59%, confirming positive operational momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline of approximately 14.10%, reflecting investor disappointment and concerns about future performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on gross margins.
2Details on product demand trends, especially in key segments like renal care.
3Management's outlook on market conditions and competitive pressures.
4Guidance on future revenue growth and potential new product launches.
5Responses to any questions about regulatory changes affecting the healthcare sector.